ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$60.46
+0.19 (+0.32%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-47.6% upside
Low Target
$20.91
Average Target
$31.67
High Target
$36.06
Current Price
$60.46
Current
$60.46
$60.46
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Scenario Analysis
Bear Case
$20.91
-65.4%
Low target
Base Case
$31.67
-47.6%
Avg target
Bull Case
$36.06
+-40.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$62.32
-3.0% from high
52-Week Low
$14.79
+308.9% from low
Target vs 52W High
$31.67
-49.2% vs high
Next Earnings Report
Aug 19, 2026
9d
until earnings
EPS Est: $-0.41
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals